RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Free Cash Flow of -$109213.0 for Q1 2026, up 41.67% on a YoY basis from -$77091.6 in Q1 2025, and up 14.82% sequentially from -$128219.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 7 years of Free Cash Flow data on file, last reported at -$109213.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 41.67% year-over-year to -$109213.0; the trailing twelve-month figure through Mar 2026 stood at -$480341.0 (up 37.24% YoY), and the FY2025 full-year result was -$558350.0, up 24.74% from the prior year.
- Free Cash Flow climbed to -$109213.0 in Q1 2026, from -$128219.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $39749.0 in Q3 2023 to a low of -$290025.0 in Q4 2023.
- A 5-year average of -$121202.8 and a median of -$123810.0 in 2023 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 167.42% in 2023, while the deepest fall reached 1100.41% in 2023.
- Tracing RTGN's Free Cash Flow over 5 years: stood at -$33225.0 in 2022, then sank by 772.91% to -$290025.0 in 2023, then soared by 35.73% to -$186390.0 in 2024, then surged by 31.21% to -$128219.0 in 2025, then advanced by 14.82% to -$109213.0 in 2026.
- Business Quant data shows RTGN's Free Cash Flow at -$109213.0 in Q1 2026, -$128219.0 in Q4 2025, and -$103837.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |